Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. L. Baykova"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 480-498 (2023)
Scientific relevance. The clinical effects and the expiration of patents for original (reference) biotechnological medicines based on monoclonal antibodies (mAbs) stimulated the development of biosimilar mAbs. The quality profile of a biosimilar mAb
Externí odkaz:
https://doaj.org/article/a238d050a1dd47959698a4419c4b9c0f
Autor:
O. V. Golovinskaya, M. L. Baykova, N. A. Alpatova, D. A. Zubkov, V. V. Fomenko, L. A. Gayderova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 3, Pp 193-201 (2020)
Assessment of specific activity of Russian and foreign-made filgrastim products by biological in vitro methods is performed using different types of dyes. It is important to choose one cell staining dye in order to align the procedure of filgrastim s
Externí odkaz:
https://doaj.org/article/1ab645bfc38b465bb34642e1020f20a1
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 1, Pp 68-73 (2020)
Specific antiviral activity is one of the key indicators characterising pharmaceutical quality and pharmacological efficacy of interferon alpha products (IFN-α). Specific activity is determined using a bioassay measuring antiviral activity in cell c
Externí odkaz:
https://doaj.org/article/a35ef6aa98554ff8a13b27413037261d
Autor:
O. B. Ustinnikova, L. A. Gayderova, M. L. Baykova, T. N. Lobanova, I. M. Shcherbachenko, E. O. Goloshchapova, V. P. Bondarev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 3, Pp 152-157 (2018)
The article summarises methods used to control the quality of recombinant interferon alpha and beta (IFNs) products. It demonstrates that currently used methodological approaches generally ensure proper quality control of this group of medicines. How
Externí odkaz:
https://doaj.org/article/8fe1bcef9f3c4b85b160392342689d8d